항바이러스제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 약물 종류별, 유통 채널별, 용도별, 지역별, 경쟁별(2020-2030년)
Anti-Viral Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Drug Class, By Distribution Channel, By Application By Region and Competition, 2020-2030F
상품코드:1878894
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 181 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 항바이러스제 시장은 2024년에 771억 달러로 평가되었으며, 2030년까지 CAGR 3.89%로 성장하여 969억 4,000만 달러에 달할 것으로 예측됩니다.
항바이러스제는 숙주 내에서 바이러스의 복제 및 증식을 억제하기 위해 개발된 의약품으로 HIV, 간염, 독감 등의 바이러스 감염증의 치료 또는 예방에 사용됩니다. 시장 성장은 주로 전 세계 바이러스성 질환의 발생률 증가, 의약품 연구개발에 대한 막대한 투자, 감염 방지를 위한 적극적인 공중보건 캠페인에 의해 주도되고 있습니다.
The Global Anti-Viral Drugs Market, valued at USD 77.10 Billion in 2024, is projected to experience a CAGR of 3.89% to reach USD 96.94 Billion by 2030. Antiviral drugs are pharmaceutical agents developed to inhibit viral replication and proliferation within a host, thereby treating or preventing viral infections such as HIV, hepatitis, and influenza. The market's growth is primarily driven by the escalating global incidence of viral diseases, substantial investments in pharmaceutical research and development, and proactive public health campaigns for infection control.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 77.10 Billion
Market Size 2030
USD 96.94 Billion
CAGR 2025-2030
3.89%
Fastest Growing Segment
Branded
Largest Market
North America
Key Market Drivers
The increasing global prevalence of viral infections stands as a significant driver for the antiviral drugs market, creating an enduring demand for effective therapeutic solutions. The continuous emergence of new viral strains and the persistent burden of established pathogens pose substantial public health challenges, from seasonal outbreaks to widespread epidemics. For example, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) in its 2023 Global AIDS Update, an estimated 1.3 million people worldwide became newly infected with HIV in 2022. This ongoing incidence necessitates the development of advanced antiviral treatments to manage and prevent disease progression, thereby directly influencing market demand for these crucial pharmaceutical products.
Key Market Challenges
The rapid evolution of viral resistance to existing therapeutic agents presents a significant obstacle to the sustained growth of the global anti-viral drugs market. As viruses mutate and develop resistance, the efficacy of current treatments diminishes, necessitating the continuous development of novel compounds. This ongoing requirement for new pharmaceutical agents directly impedes market expansion by escalating development costs and increasing regulatory complexities.
Key Market Trends
The growing adoption of AI-driven drug discovery for antivirals represents a significant shift in pharmaceutical research, aiming to accelerate the identification and development of novel compounds. This trend leverages advanced computational techniques to analyze vast biological datasets, predict molecular properties, and optimize drug designs, thereby streamlining the notoriously lengthy and expensive drug development process. According to a survey from cloud vendor Rackspace Technology and Dell/VMware conducted in October 2023, 67% of pharmaceutical companies planned to increase their IT investments, including AI, over the subsequent 12 months, highlighting this strategic pivot.
Key Market Players
F. Hoffmann-La Roche Ltd
GSK plc.
AbbVie, Inc.
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
Bristol-Myers Squibb Company
Aurobindo Pharma
Cipla Limited
Dr. Reddy's Laboratories Ltd.
Report Scope:
In this report, the Global Anti-Viral Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Anti-Viral Drugs Market, By Type:
Branded
Generics
Anti-Viral Drugs Market, By Drug Class:
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protease Inhibitors
Neuraminidase Inhibitors
Others
Anti-Viral Drugs Market, By Application:
HIV
Hepatitis
Herpes
Influenza
Others
Anti-Viral Drugs Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Anti-Viral Drugs Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Anti-Viral Drugs Market.
Available Customizations:
Global Anti-Viral Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Anti-Viral Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Branded, Generics)
5.2.2. By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others)
5.2.3. By Application (HIV, Hepatitis, Herpes, Influenza, Others)
5.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Anti-Viral Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Drug Class
6.2.3. By Application
6.2.4. By Distribution Channel
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Anti-Viral Drugs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Drug Class
6.3.1.2.3. By Application
6.3.1.2.4. By Distribution Channel
6.3.2. Canada Anti-Viral Drugs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Drug Class
6.3.2.2.3. By Application
6.3.2.2.4. By Distribution Channel
6.3.3. Mexico Anti-Viral Drugs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Drug Class
6.3.3.2.3. By Application
6.3.3.2.4. By Distribution Channel
7. Europe Anti-Viral Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Drug Class
7.2.3. By Application
7.2.4. By Distribution Channel
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Anti-Viral Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Drug Class
7.3.1.2.3. By Application
7.3.1.2.4. By Distribution Channel
7.3.2. France Anti-Viral Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Drug Class
7.3.2.2.3. By Application
7.3.2.2.4. By Distribution Channel
7.3.3. United Kingdom Anti-Viral Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Drug Class
7.3.3.2.3. By Application
7.3.3.2.4. By Distribution Channel
7.3.4. Italy Anti-Viral Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Drug Class
7.3.4.2.3. By Application
7.3.4.2.4. By Distribution Channel
7.3.5. Spain Anti-Viral Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Drug Class
7.3.5.2.3. By Application
7.3.5.2.4. By Distribution Channel
8. Asia Pacific Anti-Viral Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Drug Class
8.2.3. By Application
8.2.4. By Distribution Channel
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Anti-Viral Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Drug Class
8.3.1.2.3. By Application
8.3.1.2.4. By Distribution Channel
8.3.2. India Anti-Viral Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Drug Class
8.3.2.2.3. By Application
8.3.2.2.4. By Distribution Channel
8.3.3. Japan Anti-Viral Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Drug Class
8.3.3.2.3. By Application
8.3.3.2.4. By Distribution Channel
8.3.4. South Korea Anti-Viral Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Drug Class
8.3.4.2.3. By Application
8.3.4.2.4. By Distribution Channel
8.3.5. Australia Anti-Viral Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Drug Class
8.3.5.2.3. By Application
8.3.5.2.4. By Distribution Channel
9. Middle East & Africa Anti-Viral Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Drug Class
9.2.3. By Application
9.2.4. By Distribution Channel
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Anti-Viral Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Drug Class
9.3.1.2.3. By Application
9.3.1.2.4. By Distribution Channel
9.3.2. UAE Anti-Viral Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Drug Class
9.3.2.2.3. By Application
9.3.2.2.4. By Distribution Channel
9.3.3. South Africa Anti-Viral Drugs Market Outlook
